BRPI0812280A2 - Terapia de combinação para o tratamento de câncer compreendendo vinflunina e trastuzumab. - Google Patents
Terapia de combinação para o tratamento de câncer compreendendo vinflunina e trastuzumab.Info
- Publication number
- BRPI0812280A2 BRPI0812280A2 BRPI0812280-6A2A BRPI0812280A BRPI0812280A2 BR PI0812280 A2 BRPI0812280 A2 BR PI0812280A2 BR PI0812280 A BRPI0812280 A BR PI0812280A BR PI0812280 A2 BRPI0812280 A2 BR PI0812280A2
- Authority
- BR
- Brazil
- Prior art keywords
- vinflunine
- trastuzumab
- combination therapy
- cancer treatment
- understanding
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000002648 combination therapy Methods 0.000 title 1
- 229960000575 trastuzumab Drugs 0.000 title 1
- NMDYYWFGPIMTKO-HBVLKOHWSA-N vinflunine Chemical compound C([C@@](C1=C(C2=CC=CC=C2N1)C1)(C2=C(OC)C=C3N(C)[C@@H]4[C@@]5(C3=C2)CCN2CC=C[C@]([C@@H]52)([C@H]([C@]4(O)C(=O)OC)OC(C)=O)CC)C(=O)OC)[C@H]2C[C@@H](C(C)(F)F)CN1C2 NMDYYWFGPIMTKO-HBVLKOHWSA-N 0.000 title 1
- 229960000922 vinflunine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07290679A EP1997534A1 (en) | 2007-05-31 | 2007-05-31 | Cancer treatment combination therapy comprising vinflunine and trastuzumab |
| PCT/EP2008/056620 WO2008145697A1 (en) | 2007-05-31 | 2008-05-29 | Cancer treatment combination therapy comprising vinflunine and trastuzumab |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0812280A2 true BRPI0812280A2 (pt) | 2014-11-18 |
Family
ID=38353425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0812280-6A2A BRPI0812280A2 (pt) | 2007-05-31 | 2008-05-29 | Terapia de combinação para o tratamento de câncer compreendendo vinflunina e trastuzumab. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20100196363A1 (enExample) |
| EP (2) | EP1997534A1 (enExample) |
| JP (1) | JP2010528091A (enExample) |
| KR (1) | KR20100017752A (enExample) |
| CN (1) | CN101687104A (enExample) |
| AR (1) | AR066778A1 (enExample) |
| AU (1) | AU2008257555A1 (enExample) |
| BR (1) | BRPI0812280A2 (enExample) |
| CA (1) | CA2689664A1 (enExample) |
| CL (1) | CL2008001589A1 (enExample) |
| IL (1) | IL202393A0 (enExample) |
| MX (1) | MX2009012874A (enExample) |
| NO (1) | NO20093536L (enExample) |
| RU (1) | RU2009146882A (enExample) |
| TN (1) | TN2009000490A1 (enExample) |
| TW (1) | TW200908976A (enExample) |
| WO (1) | WO2008145697A1 (enExample) |
| ZA (1) | ZA200908247B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| TWI472339B (zh) | 2008-01-30 | 2015-02-11 | Genentech Inc | 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物 |
| BRPI0812682A2 (pt) | 2008-06-16 | 2010-06-22 | Genentech Inc | tratamento de cáncer de mama metastático |
| RU2737727C2 (ru) | 2013-04-16 | 2020-12-02 | Дженентек, Инк. | Варианты пертузумаба и их аналитическая характеристика |
| WO2018007554A1 (en) * | 2016-07-06 | 2018-01-11 | Pierre Fabre Medicament | Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination |
| TWI729259B (zh) | 2017-01-17 | 2021-06-01 | 美商建南德克公司 | 皮下her2 抗體調配物 |
| CN114984206A (zh) | 2017-03-02 | 2022-09-02 | 基因泰克公司 | Her2阳性乳腺癌的辅助治疗 |
| KR20230030621A (ko) | 2020-06-29 | 2023-03-06 | 제넨테크, 인크. | 퍼투주맙 + 트라스투주맙 고정 용량 조합 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2707988B1 (fr) * | 1993-07-21 | 1995-10-13 | Pf Medicament | Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant. |
| FR2863891B1 (fr) * | 2003-12-23 | 2006-03-24 | Pf Medicament | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation |
-
2007
- 2007-05-31 EP EP07290679A patent/EP1997534A1/en not_active Ceased
-
2008
- 2008-05-05 US US12/602,127 patent/US20100196363A1/en not_active Abandoned
- 2008-05-12 TW TW097117418A patent/TW200908976A/zh unknown
- 2008-05-29 MX MX2009012874A patent/MX2009012874A/es not_active Application Discontinuation
- 2008-05-29 WO PCT/EP2008/056620 patent/WO2008145697A1/en not_active Ceased
- 2008-05-29 KR KR1020097025793A patent/KR20100017752A/ko not_active Withdrawn
- 2008-05-29 AU AU2008257555A patent/AU2008257555A1/en not_active Abandoned
- 2008-05-29 CA CA2689664A patent/CA2689664A1/en not_active Abandoned
- 2008-05-29 BR BRPI0812280-6A2A patent/BRPI0812280A2/pt not_active IP Right Cessation
- 2008-05-29 RU RU2009146882/15A patent/RU2009146882A/ru not_active Application Discontinuation
- 2008-05-29 JP JP2010509824A patent/JP2010528091A/ja not_active Withdrawn
- 2008-05-29 CN CN200880017406A patent/CN101687104A/zh active Pending
- 2008-05-29 EP EP08760211A patent/EP2164573A1/en not_active Withdrawn
- 2008-05-30 CL CL2008001589A patent/CL2008001589A1/es unknown
- 2008-05-30 AR ARP080102281A patent/AR066778A1/es not_active Application Discontinuation
-
2009
- 2009-11-23 TN TNP2009000490A patent/TN2009000490A1/fr unknown
- 2009-11-23 ZA ZA200908247A patent/ZA200908247B/xx unknown
- 2009-11-29 IL IL202393A patent/IL202393A0/en unknown
- 2009-12-16 NO NO20093536A patent/NO20093536L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20093536L (no) | 2009-12-16 |
| EP2164573A1 (en) | 2010-03-24 |
| CA2689664A1 (en) | 2008-12-04 |
| JP2010528091A (ja) | 2010-08-19 |
| RU2009146882A (ru) | 2011-07-10 |
| US20100196363A1 (en) | 2010-08-05 |
| AR066778A1 (es) | 2009-09-09 |
| TN2009000490A1 (en) | 2011-03-31 |
| MX2009012874A (es) | 2010-03-31 |
| WO2008145697A1 (en) | 2008-12-04 |
| CL2008001589A1 (es) | 2009-03-06 |
| EP1997534A1 (en) | 2008-12-03 |
| CN101687104A (zh) | 2010-03-31 |
| AU2008257555A1 (en) | 2008-12-04 |
| TW200908976A (en) | 2009-03-01 |
| KR20100017752A (ko) | 2010-02-16 |
| IL202393A0 (en) | 2010-06-30 |
| ZA200908247B (en) | 2010-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0818320A2 (pt) | composição para tratamento de câncer de próstata (pca) | |
| BRPI0821660A2 (pt) | Combinações de agentes terapêuticos para tratamento de câncer | |
| ZA201004403B (en) | Therapeutic cancer treatments | |
| BRPI0810206A2 (pt) | Método de tratar câncer | |
| IL197217B (en) | Novel anti-cd38 antibodies for the treatment of cancer | |
| ZA200807934B (en) | Cancer treatments | |
| BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
| BRPI0813364A2 (pt) | Métodos de diagnóstico e tratamento de câncer. | |
| BRPI1010874A2 (pt) | composição para o tratamento de câncer de próstata | |
| BRPI1007995A2 (pt) | orto-aminoamidas para o tratamento de cãncer. | |
| BRPI0922884A2 (pt) | compostos para tratamento de câncer | |
| BRPI0812280A2 (pt) | Terapia de combinação para o tratamento de câncer compreendendo vinflunina e trastuzumab. | |
| BRPI0808814A2 (pt) | Anticorpos monoclonais para o tratamento do câncer | |
| BRPI0818170A2 (pt) | 5-cianotienopiridinas para o tratamento de tumores. | |
| DK2147122T3 (da) | Enzymatisk kræftbehandling | |
| BRPI0919857A2 (pt) | tratamentos para cancer com radiacao e imunocitocinas | |
| BRPI0812932A2 (pt) | Composições e métodos de tratar câncer | |
| BRPI0922367A2 (pt) | enzastaurin para o tratamento de câncer | |
| HUE038563T2 (hu) | Rák kezelési eljárás | |
| EP2144887A4 (en) | PHARMACEUTICAL FORMS AND METHOD FOR THE TREATMENT OF CANCER | |
| BRPI0810207A2 (pt) | Métodos e composições para o tratamento de câncer | |
| EP2029156A4 (en) | COMBINATION THERAPY FOR CANCER TREATMENT | |
| BRPI0918508A2 (pt) | orto-aminoanilidas para o tratamento de câncer | |
| BRPI0918407A2 (pt) | compostos organoarsênicos e métodos para o tratamento de câncer | |
| BRPI0821100A2 (pt) | composições e métodos para o tratamento de câncer de bexiga |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |